Amgen (AMGN) Net Margin (2009 - 2026)
Amgen (AMGN) posted quarterly Net Margin of 21.11% for Q1 2026, down 12.0% year-over-year from 23.99% in Q1 2025, and up 56.22% quarter-over-quarter from 13.51% in Q4 2025.
Amgen (AMGN) Net Margin (2009 - 2026) Analysis & Trends
Amgen's Net Margin history runs 18 years deep, the most recent figure standing at 21.11% for Q1 2026.
- In Q1 2026, Net Margin fell 12.0% year-over-year to 21.11%; the TTM figure through Mar 2026 stood at 20.96% (up 357.0% YoY), while the FY2025 annual figure was 20.98%, up 875.0% from the prior year.
- Net Margin for Q1 2026 stood at 21.11%, up from 13.51% in the prior quarter.
- The five-year high for Net Margin was 352.07% in Q4 2022, with the low at 1.52% in Q1 2024.
- The 5-year median for Net Margin is 21.11% (2026), against an average of 40.07%.
- The sharpest annual moves came in 2022 and 2023: Net Margin surged 32433 bps in 2022, then tumbled 34271 bps in 2023.
- Amgen's Net Margin stood at 352.07% in 2022, then plunged by 97 bps to 9.36% in 2023, then slipped by 26 bps to 6.9% in 2024, then soared by 96 bps to 13.51% in 2025, then jumped by 56 bps to 21.11% in 2026.
- Business Quant data shows AMGN's Net Margin at 21.11% in Q1 2026, 13.51% in Q4 2025, and 33.65% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 22.65% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 16.30% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1.58% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 5.17% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 2.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.62% |
| Mar 31, 2026 | 21.11% |
| Dec 31, 2025 | 13.51% |
| Sep 30, 2025 | 33.65% |
| Jun 30, 2025 | 15.60% |
| Mar 31, 2025 | 21.23% |
| Dec 31, 2024 | 6.90% |
| Sep 30, 2024 | 33.28% |
| Jun 30, 2024 | 8.89% |
| Mar 31, 2024 | -1.52% |
| Dec 31, 2023 | 9.36% |
| Sep 30, 2023 | 25.06% |
| Jun 30, 2023 | 19.74% |
| Mar 31, 2023 | 46.54% |
| Dec 31, 2022 | 352.07% |
| Sep 30, 2022 | 32.22% |
| Jun 30, 2022 | 19.97% |
| Mar 31, 2022 | 23.66% |
| Dec 31, 2021 | 27.74% |
| Sep 30, 2021 | 28.09% |